Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Interventional Study: Somatrogon Impact on Outcomes in Naive Small for Gestational Age or Idiopathic Short Stature Pediatric Patients Compared With Daily Growth Hormone

NCT07226089 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT07226089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07226089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Interventional Study: Somatrogon Impact on Outcomes in Naive Small for Gestational Age or Idiopathic Short Stature Pediatric Patients Compared With Daily Growth Hormone
Lead sponsor
Rabin Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2026
Completion date
January 31, 2028
Enrollment
254 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

iss, sga